||1. Chan, S.Y., K. Li, J.R. Piccotti, M.C. Louie, T.A. Judge, L.A. Turka, E.J. Eichwald, and D.K. Bishop. 1999. Tissue specific consequences of the anti-adenoviral immune response: Implications for cardiac transplants. Nature Medicine 5:1143-1149.
2. Chan, S.Y., R.E. Goodman, J.R. Szmuskovicz, B. Roessler, E.J. Eichwald, and D.K. Bishop. 2000. Rapid Communication: DNA-liposome versus adenoviral mediated gene transfer of TGF b 1 in vascularized cardiac allografts: Differential sensitivity of CD4+ and CD8+ T cells to TGF b 1. Transplantation 70:1292-1301.
3. Bishop, D.K., S.Y. Chan, E.J. Eichwald, and C.G. Orosz. 2001. Immunobiology of allograft rejection in the absence of interferon-gamma: CD8+ effector cells develop independent of CD4+ cells and CD40 - CD40L interactions. J. Immunol. 166:3248-3255.
4. Nathan, M.J., D. Yin, E.J. Eichwald, and D.K. Bishop. 2002. The immunobiology of inductive anti-CD40L therapy in transplantation: Allograft acceptance is not dependent upon the deletion of graft-reactive T cells. Amer. J. Transplant. 2:323-332.
5. Csencsits, K. and D.K. Bishop. 2003. Contrasting alloreactive CD4+ and CD8+ cells: There's more to it than MHC restriction. Amer. J. Transplant. 3:107-115.
6. Nathan, M.J., J.E. Mold, S.C. Wood, G. Lu, E.J. Eichwald, and D.K. Bishop. 2004. Requirements for donor and recipient CD40 expression in cardiac allograft rejection: Induction of Th1 responses and influence of donor-derived dendritic cells. J. Immunol. 172:6626-6633.
7. Csencsits, K., S.C. Wood, J.C. Magee, E.J. Eichwald, C.-H. Chang, and D.K. Bishop. 2005. Graft rejection following indirect presentation of donor alloantigen is associated with a dominant Th2 response. Eur. J. Immunol. 35:843-851.
8. Csencsits, K., S.C. Wood, G. Lu, and D.K. Bishop. 2005. Transforming growth factor-beta1 gene transfer is associated with the development of regulatory cells. Amer. J. Transplant. 5:2378-2384.
9. Csencsits, K., S.C. Wood, G. Lu, S.M. Faust, D. Brigstock, E.J. Eichwald, C.G. Orosz, and D.K. Bishop. 2006. Transforming growth factor beta-induced connective tissue growth factor and chronic allograft rejection. Amer. J. Transplant. 6:959-966.
||1. B.E. Burrell, K. Csencsits, G. Lu, S. Grabauskiene, and D.K. Bishop. CD8+ Th17 mediate costimulation blockade resistant allograft rejection in T-bet deficient mice. (J. Immunol., In Press).
2. Wood, S.C., G. Lu, B.E. Burrell, and D.K. Bishop. Immunobiology of transplant acceptance following anti-CD4 vs. anti- CD40 ligand therapy: Evidence for differential maintenance of graft-reactive T cells. (Amer. J. Transplant., In Press).
3. Csencsits, K., B.E. Burrell, G. Lu, E.J. Eichwald, G.L. Stahl, and D.K. Bishop. The classical complement pathway in transplantation: Unanticipated protective effects of C1q and role in inductive antibody therapy. (Amer. J. Transplant., In Press).